Cancer Research AACR Legacy  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 5110-5116, November 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenauer, A.
Right arrow Articles by Miller, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenauer, A.
Right arrow Articles by Miller, W. H., Jr.

Estrogen Receptor Expression Activates the Transcriptional and Growth-inhibitory Response to Retinoids without Enhanced Retinoic Acid Receptor {alpha} Expression1

Angelika Rosenauer, Clara Nervi, Kelly Davison, William W. Lamph, Sylvie Mader and Wilson H. Miller, Jr.2

Lady Davis Institute for Medical Research, SMBD Jewish General Hospital, McGill University, Montréal, Québec H3T 1E2, Canada [A. R., K. D., W. H. M.]; Dipartimento di Istologia and Embriologia Medica, Università di Roma "La Sapienza," 14,00161 Rome, Italy [C. N.]; Ligand Pharmaceuticals, San Diego, California 92121 [W. W. L.]; and Université de Montréal, Montréal, Québec, H3C 3J7 Canada [S. M.]

Estrogen receptor (ER)-positive human breast cancer cells are hormonally regulated and are inhibited by retinoids, whereas most ER-negative breast cancer cells are not. Here, we compared retinoid-induced transcriptional activation and growth inhibition in the ER-negative breast cancer cell line MDA-MB-231, stably transfected to express wild-type ER (S30), with that of the ER-positive MCF-7 line and the ER-negative parental line. Retinoids inhibited growth of the ER-expressing S30 clone but not of the parental MDA-MB-231 cells. Unlike a previously reported MDA-MB-231 subclone that was transfected to express a mutated ER (G400V), S30 did not express increased levels of retinoid receptor RNA or protein, nor was there increased binding activity to retinoid-responsive DNA elements. However, stable expression of ER increased retinoid activation of transcription of a retinoic acid (RA) response elements from the low level in MDA-MB-231 to approach the level of MCF-7. The restored growth inhibition and transcriptional regulation by RA were unaffected by treatment with ER agonists or antagonists. Transient expression of ER but not of other nuclear receptors in MDA-MB-231 cells also activated retinoid-induced transcription, showing that this response is specific to ER. Furthermore, the effect of exogenously expressed ER on retinoid response was much greater than that obtained by overexpression of RA receptor {alpha} and/or retinoid X receptor {alpha}. Finally, a panel of ER mutants showed that enhancement of retinoid-induced transcriptional activity was dependent on the integrity of the DNA binding domain.

1 This work was supported by the Cancer Research Society, McGill Center for Translational Research; by Fonds pour la Formation de Chercheurs et l'Aide à la Recherche; by the London Life Award in Medical Research; and, in part, by the Associazione Italiana per la Ricerca sul Cancro. W. H. M. is a Scholar of the Medical Research Council of Canada, S. M. is a recipient of a Chercheur Boursier award from the Fond de Recherche en Santé de Quebec, and K. D. is supported by a Fonds de la Recherche en Santé du Quebec/Fonds pour la Formation et l'Aide à la Recherche studentship.

2 To whom requests for reprints should be addressed, at Lady Davis Institute for Medical Research, 3755 Chemin de la Cote-Ste-Catherine, Montréal, Québec H3T 1E2, Canada. Phone: (514) 340-8222 ext. 4365; Fax: (514) 340-7576; E-mail: WMiller@LDI.JGH.mcgill.ca.

Received 6/24/98. Accepted 9/17/98.




This article has been cited by other articles:


Home page
JNMHome page
S. J. Lim, J. C. Paeng, S. J. Kim, S. Y. Kim, H. Lee, and D. H. Moon
Enhanced Expression of Adenovirus-Mediated Sodium Iodide Symporter Gene in MCF-7 Breast Cancer Cells with Retinoic Acid Treatment
J. Nucl. Med., March 1, 2007; 48(3): 398 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. White, M. M. Yore, D. Deng, and M. J. Spinella
Limiting Effects of RIP140 in Estrogen Signaling: POTENTIAL MEDIATION OF ANTI-ESTROGENIC EFFECTS OF RETINOIC ACID
J. Biol. Chem., March 4, 2005; 280(9): 7829 - 7835.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. Rousseau, J. N. Nichol, F. Pettersson, M.-C. Couture, and W. H. Miller Jr.
ER{beta} Sensitizes Breast Cancer Cells to Retinoic Acid: Evidence of Transcriptional Crosstalk
Mol. Cancer Res., September 1, 2004; 2(9): 523 - 531.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Zhang, N. Champagne, L. K. Beitel, C. G. Goodyer, M. Trifiro, and A. LeBlanc
Estrogen and Androgen Protection of Human Neurons against Intracellular Amyloid {beta}1-42 Toxicity through Heat Shock Protein 70
J. Neurosci., June 9, 2004; 24(23): 5315 - 5321.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. K. Mann, A. Rephaeli, A. L. Colosimo, Z. Diaz, A. Nudelman, I. Levovich, Y. Jing, S. Waxman, and W. H. Miller Jr.
A Retinoid/Butyric Acid Prodrug Overcomes Retinoic Acid Resistance in Leukemias by Induction of Apoptosis
Mol. Cancer Res., October 1, 2003; 1(12): 903 - 912.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Cote, A. Rosenauer, A. Bianchini, K. Seiter, J. Vandewiele, C. Nervi, and W. H. Miller Jr
Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells
Blood, September 18, 2002; 100(7): 2586 - 2596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. I. Chen, K. M. Sommer, and K. Swisshelm
Downstream Codons in the Retinoic Acid Receptor beta -2 and beta -4 mRNAs Initiate Translation of a Protein Isoform That Disrupts Retinoid-activated Transcription
J. Biol. Chem., September 13, 2002; 277(38): 35411 - 35421.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Fukunaka, T. Saito, K. Wataba, K. Ashihara, E. Ito, and R. Kudo
Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle
Mol. Hum. Reprod., May 1, 2001; 7(5): 437 - 446.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhang, A. K. Rishi, M. I. Dawson, R. Tschang, L. Farhana, M. Boyanapalli, U. Reichert, B. Shroot, E. C. Van Buren, and J. A. Fontana
S-phase Arrest and Apoptosis Induced in Normal Mammary Epithelial Cells by a Novel Retinoid
Cancer Res., April 1, 2000; 60(7): 2025 - 2032.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.